%0 Journal Article %T Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210 %A Binghe Xu %A Bo Lan %A Dawei Wu %A Dong Qu %A Hongnan Mo %A Hongtu Zhang %A Jing Huang %A Lanying Ma %A Xi Wang %A Xuelian Chen %J Archive of "Cancer Biology & Medicine". %D 2019 %R 10.20892/j.issn.2095-3941.2018.0172 %X SHR-1210 is a new and promising anti-PD-1 agent for solid tumors. During the phase I study of SHR-1210, we encountered a novel but prevalent immune-related dermatologic toxicity: reactive capillary hemangiomas (RCHs). Thus we tried to summarize the features of RCHs and estimate their relationship with tumor response %K Reactive capillary hemangiomas %K SHR-1210 %K skin toxicity %K anti-tumor efficacy %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528453/